Express Pharma - Page 42 of 2240 - Express Pharma

Government caps margins on cancer medicines at 30%, targets ₹2,500 Cr annual savings

Lupin receives USFDA approval for Phytonadione Injectable Emulsion

Why industry-academia collaboration will shape India’s next R&D chapter

Hashgraph Group and Merck collaborate to expand Digital Product Passport platform

GSK to acquire Nuvalent for $10.6 billion to expand lung cancer portfolio

Lilly’s orforglipron outperforms oral semaglutide in Phase 3 diabetes trial

India patent office can bridge the gap with global patent search platforms

Immuneel raises ₹100 crore in Series B funding to expand CAR-T therapy operations and global presence

India’s pharma sector to reach $120 billion in five years, says Piyush Goyal

Pharma deal value rises 156.8% in May 2026: GlobalData

How India reimagined healthcare in 12 years—and what comes next

Lupin collaborates with ERN for Luforbec pMDI launch in Spain

Maiva Pharma inaugurates state-of-the-art sterile injectable manufacturing facility at Shoolagiri, India